{"id":100056,"date":"2023-06-15T00:00:00","date_gmt":"2023-06-15T00:00:00","guid":{"rendered":"https:\/\/medgoo.com\/index.php\/2023\/06\/15\/tranexamic-acid-does-not-up-functional-outcome-after-major-trauma\/"},"modified":"2023-06-20T15:57:32","modified_gmt":"2023-06-20T15:57:32","slug":"tranexamic-acid-does-not-up-functional-outcome-after-major-trauma","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2023\/06\/15\/tranexamic-acid-does-not-up-functional-outcome-after-major-trauma\/","title":{"rendered":"Tranexamic Acid Does Not Up Functional Outcome After Major Trauma"},"content":{"rendered":"<h3>\n<p>No improvement seen in favorable functional outcome at six months, but reduced risk of death at 28 days after injury<\/p>\n<\/h3>\n<p><b>By Elana Gotkine HealthDay Reporter<\/b><\/p>\n<p><b><\/b><\/p>\n<p>THURSDAY, June 15, 2023 (HealthDay News) &#8212; For adults with major trauma at risk for trauma-induced coagulopathy, tranexamic acid administered before hospital admission is not associated with improvement in favorable functional outcome at six months, according to a study published online June 14 in the <em>New England Journal of Medicine<\/em> to coincide with the annual Critical Care Reviews Meeting, held from June 14 to 16 in Belfast, Ireland.<\/p>\n<p>Russell L. Gruen, M.B., B.S., Ph.D., from the Australian National University in Canberra, and colleagues randomly assigned adults with major trauma who were at risk for trauma-induced coagulopathy to receive tranexamic acid administered before hospital admission and after arrival at the hospital or matched placebo (661 and 646 patients, respectively).<\/p>\n<p>The researchers found that survival with a favorable functional outcome at six months occurred in 53.7 and 53.5 percent of patients in the tranexamic acid and placebo groups, respectively (risk ratio, 1.00; 95 percent confidence interval, 0.90 to 1.12; P = 0.95). At 28 days after injury, 17.3 and 21.8 percent of patients in the tranexamic acid and placebo groups, respectively, had died (risk ratio, 0.79; 95 percent confidence interval, 0.63 to 0.99), and by six months, 19.0 and 22.9 percent had died (risk ratio, 0.83; 95 percent confidence interval, 0.67 to 1.03). There was no meaningful difference observed between the groups in the number of serious adverse events, including vascular occlusive events.<\/p>\n<p>&#8220;The results appear to confirm the early survival benefit of tranexamic acid, but no benefit with respect to a favorable functional outcome at six months,&#8221; write the authors of an accompanying editorial.<\/p>\n<p><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2215457\" target=\"_blank\" rel=\"noopener\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><a href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMe2305075\" target=\"_blank\" rel=\"noopener\">Editorial (subscription or payment may be required)<\/a><\/p>\n<p><a href=\"https:\/\/criticalcarereviews.com\/meeting\/ccr23\" target=\"_blank\" rel=\"noopener\">More Information<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2023 <a href=\"http:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>No improvement seen in favorable functional outcome at six months, but reduced risk of death at 28 days after injury<\/p>\n","protected":false},"author":6,"featured_media":100128,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-100056","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/100056","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=100056"}],"version-history":[{"count":1,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/100056\/revisions"}],"predecessor-version":[{"id":100127,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/100056\/revisions\/100127"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/100128"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=100056"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=100056"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=100056"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}